The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi (Q31035230)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi |
scientific article |
Statements
1 reference
The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi (English)
1 reference
Riphed Jaziri
1 reference
Stephane Lobbens
1 reference
Roberte Aubert
1 reference
Franck Péan
1 reference
Saida Lahmidi
1 reference
Martine Vaxillaire
1 reference
Isabelle Porchay
1 reference
Naïma Bellili
1 reference
Jean Tichet
1 reference
DESIR Study Group
1 reference
Identifiers
1 reference